Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Mazevet

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of thoracic radiotherapyCyrus Chargari, François Riet, Marianne Mazevet, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of chemotherapy, a basic science updateMarianne Mazevet, Maryline Moulin, Anna Llach-Martinez, et al.
Frontiers in Oncology|May 14, 2024
Automated online safety margin (GLIOVIS) for glioma surgery modelMarianne Mazevet, Christian Oberli, Sebastiano Marinelli, et al.
NAR Cancer|July 28, 2021
<i>SMARCA4</i> deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinomaKiminori Kurashima, Hideto Kashiwagi, Iwao Shimomura, et al.
Journal of Molecular and Cellular Cardiology|December 1, 2018
Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicityAnna Llach, Marianne Mazevet, Philippe Mateo, et al.
Nature Communications|August 17, 2023
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stressTaichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, et al.
Elife|August 8, 2023
EPAC1 inhibition protects the heart from doxorubicin-induced toxicityMarianne Mazevet, Anissa Belhadef, Maxance Ribeiro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2014
Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosisVirginie Monceau, Anna Llach, David Azria, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of thoracic radiotherapyCyrus Chargari, François Riet, Marianne Mazevet, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of chemotherapy, a basic science updateMarianne Mazevet, Maryline Moulin, Anna Llach-Martinez, et al.
Frontiers in Oncology|May 14, 2024
Automated online safety margin (GLIOVIS) for glioma surgery modelMarianne Mazevet, Christian Oberli, Sebastiano Marinelli, et al.
NAR Cancer|July 28, 2021
<i>SMARCA4</i> deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinomaKiminori Kurashima, Hideto Kashiwagi, Iwao Shimomura, et al.
Journal of Molecular and Cellular Cardiology|December 1, 2018
Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicityAnna Llach, Marianne Mazevet, Philippe Mateo, et al.
Nature Communications|August 17, 2023
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stressTaichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, et al.
Elife|August 8, 2023
EPAC1 inhibition protects the heart from doxorubicin-induced toxicityMarianne Mazevet, Anissa Belhadef, Maxance Ribeiro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2014
Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosisVirginie Monceau, Anna Llach, David Azria, et al.
Pageof 1